Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Long-term functional outcomes after cardiac rehabilitation in older patients. Data from the Cardiac Rehabilitation in Advanced aGE: EXercise TRaining and Active follow-up (CR-AGE EXTRA) randomised study.

Pratesi A, Baldasseroni S, Burgisser C, Orso F, Barucci R, Silverii MV, Venturini S, Ungar A, Marchionni N, Fattirolli F.

Eur J Prev Cardiol. 2019 Jun 10:2047487319854141. doi: 10.1177/2047487319854141. [Epub ahead of print]

PMID:
31180763
2.

Endoscopic skull base neurosurgical practice in the United Kingdom.

Alalade AF, Venturini S, Dorward N, Thomas N.

Br J Neurosurg. 2019 Apr 24:1-6. doi: 10.1080/02688697.2019.1606893. [Epub ahead of print]

PMID:
31018706
3.

The national motorcycle helmet law two years on: review of its impact on the epidemiology of traumatic brain injury in a major government hospital in Cambodia.

Venturini S, Still ME, Vycheth I, Nang S, Vuthy D, Park KB.

World Neurosurg. 2019 Feb 18. pii: S1878-8750(19)30373-0. doi: 10.1016/j.wneu.2019.01.255. [Epub ahead of print]

PMID:
30790736
4.

Predictive Factors of Spine Surgery Complications at a Major Government Hospital in Cambodia.

Still MEH, Venturini S, Vycheth I, Nang S, Vuthy D, Park KB.

World Neurosurg. 2019 Feb;122:e1172-e1180. doi: 10.1016/j.wneu.2018.11.014. Epub 2018 Nov 14.

PMID:
30447437
5.

Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer.

Milani M, Venturini S, Bonardi S, Allevi G, Strina C, Cappelletti MR, Corona SP, Aguggini S, Bottini A, Berruti A, Jubb A, Campo L, Harris AL, Gatter K, Fox SB, Generali D, Roviello G.

Oncotarget. 2017 Aug 14;8(45):78870-78881. doi: 10.18632/oncotarget.20239. eCollection 2017 Oct 3.

6.

Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies.

Roviello G, Andre F, Venturini S, Pistilli B, Curigliano G, Cristofanilli M, Rosellini P, Generali D.

Eur J Cancer. 2017 Nov;86:257-265. doi: 10.1016/j.ejca.2017.09.018. Epub 2017 Oct 19. Review.

PMID:
29055841
7.
8.

Rupture of the extensor hood of the fifth toe: a rare injury.

Venturini S, Gaba S, Mangwani J.

BMJ Case Rep. 2017 Feb 27;2017. pii: bcr2016217839. doi: 10.1136/bcr-2016-217839.

9.

Medical treatment in multivessels coronary disease.

Fattirolli F, Pratesi A, Venturini S.

J Cardiovasc Med (Hagerstown). 2017 Jan;18 Suppl 1:e18-e22. doi: 10.2459/JCM.0000000000000442. No abstract available.

PMID:
27763942
10.

Observational information on a temperate reef community helps understanding the marine climate and ecosystem shift of the 1980-90s.

Gatti G, Bianchi CN, Montefalcone M, Venturini S, Diviacco G, Morri C.

Mar Pollut Bull. 2017 Jan 15;114(1):528-538. doi: 10.1016/j.marpolbul.2016.10.022. Epub 2016 Oct 13.

PMID:
27743657
11.

INFORMEG, a new evaluation system for family medicine trainees: feasibility in an Italian rural setting.

Cavicchi A, Venturini S, Petrazzuoli F, Buono N, Bonetti D.

Rural Remote Health. 2016 Jul-Sept;16(3):3666. Epub 2016 Aug 10.

12.

Role of targeted agents in neuroendocrine tumors: Results from a meta-analysis.

Roviello G, Zanotti L, Venturini S, Bottini A, Generali D.

Cancer Biol Ther. 2016 Sep;17(9):883-8. doi: 10.1080/15384047.2016.1210735. Epub 2016 Jul 14. Review.

13.

Innovative method for recovery and valorization of hydroxytyrosol from olive mill wastewaters.

Bonetti A, Venturini S, Ena A, Faraloni C.

Water Sci Technol. 2016;74(1):73-86. doi: 10.2166/wst.2016.181.

PMID:
27386985
14.

Efficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials.

Rognoni C, Venturini S, Meregaglia M, Marmifero M, Tarricone R.

Clin Drug Investig. 2016 Mar;36(3):177-94. doi: 10.1007/s40261-015-0361-z. Review.

15.

Vincenzo Neri and His Legacy in Paris and Bologna.

Vanone F, Lorusso L, Venturini S.

J Hist Neurosci. 2016;25(1):51-62. doi: 10.1080/0964704X.2015.1070249.

PMID:
26684423
16.

Recreational Boating in Ligurian Marine Protected Areas (Italy): A Quantitative Evaluation for a Sustainable Management.

Venturini S, Massa F, Castellano M, Costa S, Lavarello I, Olivari E, Povero P.

Environ Manage. 2016 Jan;57(1):163-75. doi: 10.1007/s00267-015-0593-y. Epub 2015 Aug 20.

PMID:
26289349
17.

Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa.

Beltrame A, Venturini S, Crichiutti G, Meroni V, Buonfrate D, Bassetti M.

Infection. 2016 Apr;44(2):259-62. doi: 10.1007/s15010-015-0821-7. Epub 2015 Jul 14.

PMID:
26168861
18.

A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer.

Generali D, Venturini S, Rognoni C, Ciani O, Pusztai L, Loi S, Jerusalem G, Bottini A, Tarricone R.

Breast Cancer Res Treat. 2015 Jul;152(1):95-117. doi: 10.1007/s10549-015-3453-9. Epub 2015 Jun 5.

PMID:
26044370
19.

Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer.

Bazzola L, Foroni C, Andreis D, Zanoni V, R Cappelletti M, Allevi G, Aguggini S, Strina C, Milani M, Venturini S, Ferrozzi F, Giardini R, Bertoni R, Turley H, Gatter K, Petronini PG, Fox SB, Harris AL, Martinotti M, Berruti A, Bottini A, Reynolds AR, Generali D.

Br J Cancer. 2015 Jan 6;112(1):52-60. doi: 10.1038/bjc.2014.563. Epub 2014 Dec 2.

20.

Infective endocarditis in elderly: an Italian prospective multi-center observational study.

Bassetti M, Venturini S, Crapis M, Ansaldi F, Orsi A, Della Mattia A, Sinagra G, Pinamonti B, Rellini G, Moretti V, Bordin P, Rossi P, Schiavon I, Proclemer A, Livi U, Viale P; Friuli Venezia Giulia Endocarditis study group, Piazza R, Fazio G, Di Piazza V, Maschio M, Beltrame A.

Int J Cardiol. 2014 Dec 15;177(2):636-8. doi: 10.1016/j.ijcard.2014.09.184. Epub 2014 Oct 6. No abstract available.

PMID:
25449467
21.

Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms.

Italian Association of Hospital Gastroenterologists and Endoscopists; Italian Association for the Study of the Pancreas, Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, Zamboni G, Arcidiacono P, Balzano G, Barresi L, Basso D, Bocus P, Calculli L, Capurso G, Canzonieri V, Casadei R, Crippa S, D'Onofrio M, Frulloni L, Fusaroli P, Manfredi G, Pacchioni D, Pasquali C, Rocca R, Ventrucci M, Venturini S, Villanacci V, Zerbi A, Falconi M; Cystic Pancreatic Neoplasm Study Group.

Dig Liver Dis. 2014 Jun;46(6):479-93. doi: 10.1016/j.dld.2013.12.019. Epub 2014 May 5.

22.

Reducing hypothermia in preterm infants following delivery.

Russo A, McCready M, Torres L, Theuriere C, Venturini S, Spaight M, Hemway RJ, Handrinos S, Perlmutter D, Huynh T, Grunebaum A, Perlman J.

Pediatrics. 2014 Apr;133(4):e1055-62. doi: 10.1542/peds.2013-2544. Epub 2014 Mar 31.

PMID:
24685958
23.

Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy".

Foroni C, Milan M, Strina C, Cappelletti M, Fumarola C, Bonelli M, Bertoni R, Ferrero G, Maldotti M, Takano E, Andreis D, Venturini S, Brugnoli G, Petronini PG, Zanoni V, Pritzker L, Pritzker K, Parissenti A, Santini D, Fox SB, Bottini A, Generali D.

Breast Cancer Res Treat. 2014 Feb;144(1):113-21. doi: 10.1007/s10549-014-2840-y. Epub 2014 Jan 28.

PMID:
24469643
24.

HSV-1 cutaneous infection in a patient with Hodgkin's lymphoma treated with brentuximab vedotin.

Bassetti M, Pecori D, Righi E, Brillo F, Cadeo B, Venturini S, Chiozzotto M, Zaja F.

J Chemother. 2013 Dec;25(6):381-2. doi: 10.1179/1973947813Y.0000000095. Epub 2013 Dec 6. No abstract available.

PMID:
24093434
25.

Gentamicin once-daily in enterococcal endocarditis.

Bassetti M, Righi E, Crapis M, Cojutti P, Venturini S, Viale P, Pea F.

Int J Cardiol. 2013 Oct 12;168(5):5033-4. doi: 10.1016/j.ijcard.2013.07.225. Epub 2013 Jul 30. No abstract available.

PMID:
23931973
26.

Efficacy of computer-aided detection as a second reader for 6-9-mm lesions at CT colonography: multicenter prospective trial.

Regge D, Della Monica P, Galatola G, Laudi C, Zambon A, Correale L, Asnaghi R, Barbaro B, Borghi C, Campanella D, Cassinis MC, Ferrari R, Ferraris A, Hassan C, Golfieri R, Iafrate F, Iussich G, Laghi A, Massara R, Neri E, Sali L, Venturini S, Gandini G.

Radiology. 2013 Jan;266(1):168-76. doi: 10.1148/radiol.12120376. Epub 2012 Nov 14. Erratum in: Radiology. 2013 Mar;266(3):1000. Golfieri, Rita [added].

27.

New omics information for clinical trial utility in the primary setting.

Damia G, Broggini M, Marsoni S, Venturini S, Generali D.

J Natl Cancer Inst Monogr. 2011;2011(43):128-33. doi: 10.1093/jncimonographs/lgr032.

PMID:
22043059
28.

Antibody purification-independent microarrays (PIM) by direct bacteria spotting on TiO2-treated slides.

De Marni ML, Monegal A, Venturini S, Vinati S, Carbone R, de Marco A.

Methods. 2012 Feb;56(2):317-25. doi: 10.1016/j.ymeth.2011.06.008. Epub 2011 Jun 24.

PMID:
21736943
29.

Small cell lung cancer in an elderly patient: efficacy of somatostatin analog treatment, a case report.

Bearz A, Lleshi A, Perin T, Fratino L, Venturini S, Giacalone A, Sartor I, Berretta M, Sulfaro S, Tirelli U.

Onkologie. 2011;34(3):117-20. doi: 10.1159/000324669. Epub 2011 Feb 18. No abstract available.

PMID:
21358216
30.

Testing Hardy-Weinberg equilibrium: an objective Bayesian analysis.

Consonni G, Moreno E, Venturini S.

Stat Med. 2011 Jan 15;30(1):62-74. doi: 10.1002/sim.4084. Epub 2010 Oct 20.

PMID:
20963736
31.

Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer.

Regge D, Laudi C, Galatola G, Della Monica P, Bonelli L, Angelelli G, Asnaghi R, Barbaro B, Bartolozzi C, Bielen D, Boni L, Borghi C, Bruzzi P, Cassinis MC, Galia M, Gallo TM, Grasso A, Hassan C, Laghi A, Martina MC, Neri E, Senore C, Simonetti G, Venturini S, Gandini G.

JAMA. 2009 Jun 17;301(23):2453-61. doi: 10.1001/jama.2009.832.

PMID:
19531785
32.

Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.

Koh MY, Spivak-Kroizman T, Venturini S, Welsh S, Williams RR, Kirkpatrick DL, Powis G.

Mol Cancer Ther. 2008 Jan;7(1):90-100. doi: 10.1158/1535-7163.MCT-07-0463.

33.

ImmunoCell-Array: a novel technology for pathway discovery and cell profiling.

Giorgetti L, Zanardi A, Venturini S, Carbone R.

Expert Rev Proteomics. 2007 Oct;4(5):609-16. Review.

PMID:
17941816
34.

Role of magnetic resonance in characterising extrahepatic cholangiocarcinomas.

Guarise A, Venturini S, Faccioli N, Pinali L, Morana G.

Radiol Med. 2006 Jun;111(4):526-38. Epub 2006 May 25. English, Italian.

PMID:
16779539
35.

Abdominal metastases of medulloblastoma related to a ventriculoperitoneal shunt.

Loiacono F, Morra A, Venturini S, Balestreri L.

AJR Am J Roentgenol. 2006 Jun;186(6):1548-50. No abstract available.

PMID:
16714642
36.

Identification of peptides from human pathogens able to cross-activate an HIV-1-gag-specific CD4+ T cell clone.

Venturini S, Allicotti G, Zhao Y, Simon R, Burton DR, Pinilla C, Poignard P.

Eur J Immunol. 2006 Jan;36(1):27-36.

37.

Dehydrated gelatin drops: a good method for fungi maintenance and preservation.

Marangon AV, Bertoni TA, Kioshima ES, Falleiros De Pádua RA, Venturini S, Svidzinski TI.

New Microbiol. 2003 Jul;26(3):305-9.

PMID:
12901428
38.

Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies.

Poignard P, Moulard M, Golez E, Vivona V, Franti M, Venturini S, Wang M, Parren PW, Burton DR.

J Virol. 2003 Jan;77(1):353-65.

39.

Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study.

Bertelli G, Venturini M, Del Mastro L, Bergaglio M, Sismondi P, Biglia N, Venturini S, Porcile G, Pronzato P, Costantini M, Rosso R.

Ann Oncol. 2002 Jun;13(6):883-8.

PMID:
12123333
41.

Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells.

Anderson KL, Perkin H, Surh CD, Venturini S, Maki RA, Torbett BE.

J Immunol. 2000 Feb 15;164(4):1855-61.

42.

The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries.

Zwick MB, Bonnycastle LL, Noren KA, Venturini S, Leong E, Barbas CF 3rd, Noren CJ, Scott JK.

Anal Biochem. 1998 Nov 1;264(1):87-97. Erratum in: Anal Biochem 1999 Jan 15;266(2):240.

43.

Engineering minibody-like ligands by design and selection.

Sollazzo M, Venturini S, Lorenzetti S, Pinola M, Martin F.

Chem Immunol. 1997;65:1-17. Review. No abstract available.

PMID:
9018870
44.

Probing the tertiary structure of proteins by limited proteolysis and mass spectrometry: the case of Minibody.

Zappacosta F, Pessi A, Bianchi E, Venturini S, Sollazzo M, Tramontano A, Marino G, Pucci P.

Protein Sci. 1996 May;5(5):802-13.

45.

A case of thrombocytopoenic thrombotic purpura preceding onset of systemic lupus erythematosus.

Di Pietro G, Menicucci A, Venturini S, Avanzi G.

J Clin Apher. 1996;11(1):51-2. No abstract available.

PMID:
8722726
46.
47.

The affinity-selection of a minibody polypeptide inhibitor of human interleukin-6.

Martin F, Toniatti C, Salvati AL, Venturini S, Ciliberto G, Cortese R, Sollazzo M.

EMBO J. 1994 Nov 15;13(22):5303-9.

48.

The making of the minibody: an engineered beta-protein for the display of conformationally constrained peptides.

Tramontano A, Bianchi E, Venturini S, Martin F, Pessi A, Sollazzo M.

J Mol Recognit. 1994 Mar;7(1):9-24.

PMID:
7986569
49.

High level expression and rational mutagenesis of a designed protein, the minibody. From an insoluble to a soluble molecule.

Bianchi E, Venturini S, Pessi A, Tramontano A, Sollazzo M.

J Mol Biol. 1994 Feb 18;236(2):649-59.

PMID:
8107147
50.

A designed metal-binding protein with a novel fold.

Pessi A, Bianchi E, Crameri A, Venturini S, Tramontano A, Sollazzo M.

Nature. 1993 Mar 25;362(6418):367-9.

PMID:
8455724

Supplemental Content

Loading ...
Support Center